CAPR
CAPR
NASDAQ · Biotechnology

Capricor Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$33.50
+2.59 (+8.38%)
As of May 9, 1:35 AM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +86.4% upside
Low Target $34.96
Average Target $62.44
High Target $82.04
Current Price $33.50
Current
$33.50
Target
$62.44
$34.96 $62.44 avg $82.04
Scenario Analysis
Bear Case
$34.96
4.4%
Low target
Base Case
$62.44
+86.4%
Avg target
Bull Case
$82.04
+144.9%
High target
Risk/Reward
33.2x
Highly favorable
Price in Context
52-Week High
$40.37
-17.0% from high
52-Week Low
$4.30
+679.1% from low
Target vs 52W High
$62.44
+54.7% vs high
Next Earnings Report
May 12, 2026 · After Market Close
1d
tomorrow
EPS Est: $-0.53
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%